Pdt Partners, LLC Axsome Therapeutics, Inc. Transaction History
Pdt Partners, LLC
- $1.28 Billion
- Q1 2025
A detailed history of Pdt Partners, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 51,199 shares of AXSM stock, worth $5.3 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
51,199
Previous 4,195
1120.48%
Holding current value
$5.3 Million
Previous $354,000
1586.72%
% of portfolio
0.47%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
408Shares Held
36.4MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$402 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$342 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$303 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$175 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$101 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...